Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis.

MLA

Capo, Valentina, et al. “Expanded Circulating Hematopoietic Stem/Progenitor Cells as Novel Cell Source for the Treatment of TCIRG1 Osteopetrosis.” Haematologica, vol. 106, no. 1, Jan. 2021, pp. 74–86. EBSCOhost, https://doi.org/10.3324/haematol.2019.238261.

APA

Capo, V., Penna, S., Merelli, I., Barcella, M., Scala, S., Basso-Ricci, L., Draghici, E., Palagano, E., Zonari, E., Desantis, G., Uva, P., Cusano, R., Sergi Sergi, L., Crisafulli, L., Moshous, D., Stepensky, P., Drabko, K., Kaya, Z., Unal, E., … Villa, A. (2021). Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis. Haematologica, 106(1), 74–86. https://doi.org/10.3324/haematol.2019.238261

Chicago

Capo, Valentina, Sara Penna, Ivan Merelli, Matteo Barcella, Serena Scala, Luca Basso-Ricci, Elena Draghici, et al. 2021. “Expanded Circulating Hematopoietic Stem/Progenitor Cells as Novel Cell Source for the Treatment of TCIRG1 Osteopetrosis.” Haematologica 106 (1): 74–86. doi:10.3324/haematol.2019.238261.